Rare diseases
Investigational molecules
Locations
Back to Czechia8 clinical trials in Karlovy Vary, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
CzechiaOrforglipron for stress urinary incontinence in women with obesity or overweight
CzechiaStudy on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
CzechiaStudy on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
CzechiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
CzechiaStudy of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa
CzechiaStudy on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy
CzechiaStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on the intersection of obesity and cardiovascular health, evaluating new therapeutic approaches for weight management while ensuring heart safety.
Studies examine outcomes including stroke prevention, myocardial infarction, and heart failure events.
Advanced trials investigating treatments for Hidradenitis Suppurativa, focusing on novel therapeutic approaches for patients who haven't responded to conventional treatments.
Multiple studies evaluating different therapeutic agents including upadacitinib and lutikizumab.
Specialized research into atopic hand eczema treatments, evaluating innovative therapies for patients with moderate-to-severe symptoms requiring systemic intervention.
Studies focus on measuring both the severity and extent of condition improvement with new treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
